MyTrials. Making clinical trials accessible to every patient, everywhere.
A clinician on our team kept watching his patients miss out on treatments that could change their lives — not because the treatments didn't exist, but because the system to find them was built for researchers, not people.
$200k
Raised
Seed investment secured
5
Team Size
Cross-functional founders
5th
Grade Level
Target reading complexity
97%
Gap
Eligible patients who never enroll
01 — The Origin
A doctor watched his patients miss life-changing treatments
One of our co-founders was a clinician who repeatedly saw the same situation unfold: a patient with a diagnosis that qualified them for a cutting-edge clinical trial — and no idea it existed. The trials were real. The hope was real. The pathway to find them was not.
He brought the problem to our team. We immediately understood the stakes. Clinical trials aren't just research. For many patients, they represent their best option — sometimes their only option — for treatment.
Why clinical trials matter to patients
* patients who cited each benefit as a primary motivator
02 — The Problem
The data exists. The interface does not.
We discovered ClinicalTrials.gov — the US government's authoritative database containing over 400,000 active trials. The inventory exists. The problem is the interface.
Eligibility criteria reads like legal-medical hybrid text. Terms like "ECOG performance status ≤2" or "histologically confirmed NSCLC" create an impenetrable wall between patients and the treatments designed to help them. The system was built by researchers for researchers — never for patients.
97%
of eligible cancer patients
never enroll in a clinical trial
Not from reluctance. From a broken system.
03 — The Solution
AI-powered simplification, tested to a 5th-grade reading level
We used GPT-4 to translate clinical trial eligibility criteria into plain English automatically. But we didn't stop there — we ran four rigorous rounds of user testing with non-medical participants, measuring reading level via Flesch-Kincaid scoring until we hit our target without losing essential meaning.
Flesch-Kincaid Grade Level — User Testing Rounds
04 — Process
From clinical insight to funded product
01
Clinician Brief
A doctor on our team surfaced the problem: his patients were missing life-changing trials simply because they didn't know they existed.
02
Problem Validation
We mapped the clinical trial enrollment funnel. Only 3% of eligible cancer patients ever enroll — not from reluctance, but from a system that was never designed for patients.
03
Source Discovery
We identified ClinicalTrials.gov as the authoritative database with 400,000+ active trials. The data was there. The usability was not.
04
AI Simplification
We layered GPT-4 on top of the raw trial data to translate dense medical eligibility criteria into plain English that anyone could understand.
05
Readability Testing
We ran 4 rounds of user testing with patients and non-medical professionals, targeting a 5th-grade Flesch-Kincaid reading level while preserving all essential meaning.
06
Brand & Naming
I named the product 'MyTrials' — personal, possessive, and instantly clear. Matching algorithm built. Site launched. $200k raised.
05 — Skills Applied
Product management across a high-stakes domain
06 — Tech Stack
Tools that built MyTrials
Framework
Next.js
Framework
React
AI
OpenAI GPT-4
Data
ClinicalTrials.gov API
Database
PostgreSQL
Algorithm
Custom Matching Algo
Design
Figma
Language
TypeScript
07 — Investment
$200,000 raised on the strength of the mission
The investment thesis was clear: the problem is enormous and well-documented, the technology exists, and for the first time the user experience has been built for patients rather than researchers. Investors believed in both the social impact and the commercial opportunity.
$200k
Seed Round
Pre-product investment
5
Team
Clinical + tech + design
400k+
Data Source
Active ClinicalTrials.gov entries
MyTrials Inc.
mytrials.ai